Literature DB >> 11581294

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

A M Schmidt1, S D Yan, S F Yan, D M Stern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11581294      PMCID： PMC200958          DOI： 10.1172/JCI14002

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  40 in total

1.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.

Authors:  S D Yan; H Zhu; A Zhu; A Golabek; H Du; A Roher; J Yu; C Soto; A M Schmidt; D Stern; M Kindy
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 2.  Innate immunity.

Authors:  R Medzhitov; C Janeway
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

Review 3.  Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale.

Authors:  N Platt; S Gordon
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

5.  The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells.

Authors:  N Tanaka; H Yonekura; S Yamagishi; H Fujimori; Y Yamamoto; H Yamamoto
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

Review 6.  The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity.

Authors:  I P Fraser; H Koziel; R A Ezekowitz
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

7.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.

Authors:  E Lalla; I B Lamster; M Feit; L Huang; A Spessot; W Qu; T Kislinger; Y Lu; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

8.  N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression.

Authors:  T Kislinger; C Fu; B Huber; W Qu; A Taguchi; S Du Yan; M Hofmann; S F Yan; M Pischetsrieder; D Stern; A M Schmidt
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

9.  Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.

Authors:  M M Sousa; S Du Yan; R Fernandes; A Guimaraes; D Stern; M J Saraiva
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

10.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

Authors:  M T Goova; J Li; T Kislinger; W Qu; Y Lu; L G Bucciarelli; S Nowygrod; B M Wolf; X Caliste; S F Yan; D M Stern; A M Schmidt
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307
View more
  377 in total

1.  Series introduction: multiligand receptors and human disease.

Authors:  M Krieger; D M Stern
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

3.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.

Authors:  Changyong Lu; John Cijiang He; Weijing Cai; Huixian Liu; Li Zhu; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

4.  Pharmacological prevention of cardiovascular aging--targeting the Maillard reaction.

Authors:  Doron Aronson
Journal:  Br J Pharmacol       Date:  2004-07-05       Impact factor: 8.739

5.  Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex.

Authors:  Nicola Origlia; Camilla Bonadonna; Alfredo Rosellini; Elena Leznik; Ottavio Arancio; Shirley Shidu Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

6.  Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.

Authors:  Hongliang Zong; Angelina Madden; Micheal Ward; Mark H Mooney; Christopher T Elliott; Alan W Stitt
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

7.  PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease.

Authors:  Marwan N Sabbagh; Albert Agro; Joanne Bell; Paul S Aisen; Edward Schweizer; Douglas Galasko
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jul-Sep       Impact factor: 2.703

8.  The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells.

Authors:  Huan Du; Pengtao Li; Jun Wang; Xuemei Qing; Weihong Li
Journal:  Cell Mol Neurobiol       Date:  2011-08-12       Impact factor: 5.046

9.  Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation.

Authors:  John Evankovich; Travis Lear; Alison Mckelvey; Sarah Dunn; James Londino; Yuan Liu; Bill B Chen; Rama K Mallampalli
Journal:  FASEB J       Date:  2017-05-17       Impact factor: 5.191

10.  Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Authors:  Peter J Smit; Weidun A Guo; Bruce A Davidson; Barbara A Mullan; Jadwiga D Helinski; Paul R Knight
Journal:  J Surg Res       Date:  2014-04-08       Impact factor: 2.192
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.